Anti-NCAM1/CD56 Antibody (Lorvotuzumab)
Catalog No.
F1192
Anti-NCAM1/CD56 Antibody (Lorvotuzumab)
Featured Products
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is aCD56 (NCAM1) Lorvotuzumab can be used to synthesize the ADC compound Lorvotuzumab mertansine.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.44 kDa
Dry ice
/
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Lorvotuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P13591
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TT Cell Line were stained with Anti-NCAM1/CD56 Antibody (Lorvotuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.015 ug/mL.
NCAM1 / CD56
Please avoid freeze-thaw cycles.